Role of miR‐145 in human laryngeal squamous cell carcinoma

Laryngeal squamous cell carcinoma (SCC), being an aggressive malignancy, is one of the most commonly diagnosed malignant types of head and neck SCC worldwide. Incidences of laryngeal SCC have been reported to increase recently. In this study, we aimed to explore the biological effects of miR‐145 on laryngeal cancer cells.

[1]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[2]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[3]  Xinwei Chen,et al.  Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line. , 2013, International journal of clinical and experimental pathology.

[4]  B. Novitch,et al.  Vertebrate neurogenesis is counteracted by Sox1–3 activity , 2003, Nature Neuroscience.

[5]  Jialing Yuan,et al.  Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. , 2007, Cancer research.

[6]  C. Cicione,et al.  Molecular profile and cellular characterization of human bone marrow mesenchymal stem cells: donor influence on chondrogenesis. , 2010, Differentiation; research in biological diversity.

[7]  Yi-long Wu,et al.  Retrospective Analysis of Prognostic Factors in 205 Patients with Laryngeal Squamous Cell Carcinoma Who Underwent Surgical Treatment , 2013, PloS one.

[8]  Y. Toiyama,et al.  Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy , 2009, Annals of Surgical Oncology.

[9]  R. Xiang,et al.  SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell. , 2011, Journal of molecular cell biology.

[10]  M. Hussain,et al.  MicroRNAs and human diseases: diagnostic and therapeutic potential , 2014, Cell and Tissue Research.

[11]  Jing Gong,et al.  MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. , 2010, Cancer research.

[12]  Duan Ma,et al.  Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma , 2013, Head & neck.

[13]  H. Becher,et al.  Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis , 2011, European Archives of Oto-Rhino-Laryngology.

[14]  R. Morton,et al.  Epidemiology of laryngeal cancer. , 1982, Clinical otolaryngology and allied sciences.

[15]  C. Creighton,et al.  Widespread deregulation of microRNA expression in human prostate cancer , 2008, Oncogene.

[16]  Jing Liang,et al.  The Molecular Mechanism Governing the Oncogenic Potential of SOX2 in Breast Cancer* , 2008, Journal of Biological Chemistry.

[17]  G. Pan,et al.  MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells , 2009, Cell.

[18]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[19]  S. Kasper.  Exploring the Origins of the Normal Prostate and Prostate Cancer Stem Cell , 2008, Stem Cell Reviews.

[20]  E. Chu,et al.  Laryngeal cancer: diagnosis and preoperative work-up. , 2008, Otolaryngologic clinics of North America.

[21]  D. Steindler,et al.  Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells. , 2010, The Journal of urology.

[22]  E. Karaca,et al.  MicroRNA profiling in lymphocytes and serum of tyrosinemia type-I patients , 2013, Molecular Biology Reports.

[23]  Rajvir Dahiya,et al.  MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancer , 2010, Cancer.

[24]  T. Tammela,et al.  MicroRNA expression profiling in prostate cancer. , 2007, Cancer research.

[25]  Shi-Ming Chen,et al.  Identification of predictive biomarkers for early diagnosis of larynx carcinoma based on microRNA expression data. , 2013, Cancer genetics.

[26]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..